NCT05921123View on ClinicalTrials.gov

Understanding and Anticipating Therapeutic Response And Immuno-meDIated Adverse Events in Anti-cancer Immune-checkpoint Inhibition: a Tissue Biopsy Based imaGing Study

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

November 25, 2023

Primary Completion Date

November 25, 2024

Study Completion Date

November 25, 2024

Conditions
Cancer
Trial Locations (1)

29200

RECRUITING

Brest University Hospital, Brest

All Listed Sponsors
lead

University Hospital, Brest

OTHER